Document:

Profits Unit Award Agreement dated July 15, 2005

 EXHIBIT 10.58 
  
 PROFITS UNIT AWARD AGREEMENT 
  

PROFITS UNIT AWARD AGREEMENT, (“Agreement”) dated as of July 15, 2005 (the “Date of Grant”), by and between KRATON Management LLC, a Delaware
limited liability company (the “Company”) and Kevin Fogarty (the “Participant”). Unless the context otherwise provides, capitalized terms not defined herein shall have the meanings ascribed to them in the Limited Liability
Company Operating Agreement of KRATON Management LLC, as amended from time to time (the “Management LLC Agreement”). 
  
 1. Description of Profits Units. Each Company Profits Unit represents the right to a pro rata share of any distributions received by the Company in respect
of the corresponding TJ Chemical Profits Units held by the Company in accordance with the Management LLC Agreement. Each TJ Chemical Profits Unit represents the right to receive a pro rata portion of the appreciation of the assets of TJ
Chemical above the Threshold Amount (as defined in the TJ Chemical LLC Agreement) for such TJ Chemical Profits Unit after the Date of Grant. The Threshold Amount for the Company Profits Units granted hereunder is $250,019,229, representing the
current value of the assets of TJ Chemical (net of debt) as of the Date of Grant, provided that such Threshold Amount may be appropriately and equitably adjusted by the Board of Directors of TJ Chemical for contributions and distributions that
affect the aggregate balances of all Capital Accounts (as defined in the TJ Chemical LLC Agreement) maintained under the TJ Chemical LLC Agreement in order to place all holders of profits units, including the Participant, in the same position they
would have been in had such contributions and distributions not been made. The pro rata portion of appreciation shall be determined based on all outstanding TJ Chemical Membership Units and TJ Chemical Profits Units for which the applicable
Threshold Amount has been achieved (but only as to the appreciation above the Threshold Amount with respect to the applicable TJ Chemical Profits Units). 
  
 Each Company Profits Unit is intended to be a “profits interest” within the meaning of Rev. Proc. 93-27 (6/09/93) and Rev. Proc. 2001-43 (8/03/01). By
virtue of ownership of a Company Profits Unit, the Participant shall have no right or obligation to make any Capital Contribution to the Company at any time and shall have no rights to any capital contributed to the Company. 
  
 2. Grant of Award. The Company hereby grants to the Participant 300,000 Company
Profits Units (the “Profits Units”), subject to the terms and conditions of this Agreement and the Management LLC Agreement. 
  
 3. Vesting. Notwithstanding Section 4.8 of the Management LLC Agreement, 50% of the Profits Unit shall vest when the fair value of the assets of TJ Chemical
equal or exceed two times (2X) the Threshold Amount and the remaining 50% of the Profits Units shall vest when the fair value of the assets of TJ Chemical equal or exceed three times (3X) the Threshold Amount, in each case, as determined
by the Board of Directors of TJ Chemical, provided that the Participant is employed by the KRATON Group on such vesting date, and provided further that if, at the time the Company makes a determination as to whether the Participant is entitled to
any appreciation with respect to the Profits Units, the value of the assets of the Company is more 

 than two times (2X) but less than (3X) the value of the assets on the grant date, a pro-rata portion of the
second 50% will vest based on the appreciation above the amount equal to two times (2X) the value of the assets on the grant date, and provided, further, that 100% of the Profits Units shall vest upon the effective date of a disposition by the
Initial Investors of 51 % or more of their aggregate interests in KRATON to one or more unrelated third Persons if the Participant is employed by the KRATON Group through such date. Notwithstanding anything to the contrary in any other
agreement, including the Management LLC Agreement, in the event the Participant’s employment with the KRATON Group is terminated prior to a portion or all Profits Units becoming vested as provided above, all unvested Profits Units shall
immediately and without any further action be forfeited on the date of termination. 
  
 4. LLC Agreements. This Agreement shall be subject to all of the provisions of the Management LLC Agreement, and such provisions are incorporated herein by this reference. The Participant understands that, as a condition to receiving
the Profits Units granted hereunder, the Participant must execute and comply with the Management LLC Agreement. The Participant shall be a Member and holder of Profits Unit for all purposes under the Management LLC Agreement. Unless expressly stated
otherwise in this Agreement, to the extent that, with respect to any right or obligation of the Participant, any provisions of this Agreement are not consistent with the Management LLC Agreement, the provisions of the Management LLC Agreement shall
govern. 
  
 5. Representations by Participant. The Participant represents
and warrants that he has received, read and executed a copy of the Management LLC Agreement. 
  
 6. Restrictions on Transferability. Except as specifically provided in Article IX of the Management LLC Agreement, the Profits Units may not be sold, transferred or otherwise disposed of without the written
approval of the Managing Member. 
  
 7. Corporate Transaction: Termination of
Employment. The Company shall have the right to cancel the Profits Units in the event of a merger, consolidation, recapitalization or other corporate transaction involving TJ Chemical in which TJ Chemical cancels the corresponding TJ Chemical
Profits Units and shall distribute the cash, securities or other property, or any combination thereof, if any, received from TJ Chemical in respect of such corresponding TJ Chemical Profits Units in accordance with Section 9.6 of the Management
LLC Agreement. If the Participant becomes a Terminated Employee, the Company shall have the right to purchase any then-vested Profits Units held by the Participant in accordance with Article IX of the Management LLC Agreement. 
  
 8. Fair Value. Any determination relating to the value of the assets of TJ Chemical or
any TJ Chemical Profits Unit shall be determined in good faith by the Board of Directors of TJ Chemical in accordance with the TJ Chemical LLC Agreement and all determinations of the Board of Directors shall be final and binding on all parties.

  
 9. Assignment. This Agreement and the rights hereunder shall not be
assignable or transferable by the Participant without the prior written consent of the Company. This Agreement shall inure to the benefit of and be binding upon the parties and to their respective heirs, executors, administrators, successors and
permitted assigns. 

 10. Amendments. The terms and provisions of this Agreement may not be amended except by a written instrument
signed by the parties hereto. 
  
 11. Counterparts: Effectiveness. This
Agreement may be executed in any number of counterparts, each of which shall be considered an original, but all such counterparts shall together constitute but one and the same contract. 
  
 12. Severability. Every provision of this Agreement is intended to be severable. If any term or provision hereof is illegal or
invalid for any reason whatsoever, such term or provision shall be enforced to the maximum extent permitted by law and, in any event, such illegality or invalidity shall not affect the validity of the remainder of this Agreement. 
  
 13. Non-Waiver. No provision of this Agreement shall be deemed to have been waived
except if the giving of such waiver is contained in a written notice given to the party claiming such waiver, and no such waiver shall be deemed to be a waiver of any other or further obligation or liability of the party or parties in whose favor
the waiver was given. 
  
 14. Applicable Law. This Agreement and the rights
and obligations of the parties hereto shall be interpreted and enforced in accordance with and governed by the laws of the state of Delaware without regard to its principles of conflict of laws. 
  
 15. Integration. This Agreement, and the other documents referred to herein or
delivered pursuant hereto (including, without limitation, the Management LLC Agreement and the TJ Chemical LLC Agreement) which form a part hereof contain the entire understanding of the parties with respect to its subject matter and there are no
restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth in such documents and such documents supersede all prior agreements and
understandings between the parties with respect to their subject matter. 

 IN WITNESS WHEREOF, the Company and the Participant have duly executed this Agreement as of the day and year first above
written. 
  

			
	 KRATON MANAGEMENT LLC

		
	 By:
	 	/s/ David Spuria
	 Name:
	 	David Spuria
	 Title:
	 	Vice-President
	
	 KEVIN FOGARTY

	
	 /s/ Kevin FogartyRule 10b5-1 Sales Plan

 EXHIBIT 10.1 
  
 Rule 10b5-1 Sales Plan 
  
 For 
  
 Joseph L. von Rosenberg III 
  
 Sales Plan 
  
 Sales Plan
dated August 25, 2005 (this “Sales Plan”) between Joseph L. von Rosenberg III (“Seller”) and Morgan Stanley DW Inc. (“Morgan Stanley”), acting as agent for Seller. 
  
 A. Recitals 
  
 1. This Sales Plan is entered into between Seller and Morgan Stanley for the purpose of establishing a trading plan that
complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). 
  
 2. Seller is establishing this Sales Plan in order to permit the orderly disposition of a portion of Seller’s holdings of the common stock, par value
$0.01 per share (the “Stock”), of Omega Protein Corporation (the “Issuer”), including Stock that Seller has the right to acquire under the outstanding stock options issued by the Issuer listed on Schedule A hereto (the
“Options”). 
  
 B. Seller’s Representations, Warranties and
Covenants 
  
 1. As of the date hereof, Seller is not
aware of any material nonpublic information concerning the Issuer or its 

 securities. Seller is entering into this Sales Plan in good faith and not as part of a plan or scheme to evade compliance
with the federal securities laws. 
  
 2. The securities to be sold
under this Sales Plan are owned free and clear by Seller (subject, in the case of shares underlying Options, only to the compliance by Seller with the exercise provisions of such Options) and are not subject to any agreement granting any pledge,
lien, mortgage, hypothecation, security interest, charge, option or encumbrance or any other limitation on disposition, other than those which may have been entered into between Seller and Morgan Stanley or imposed by Rule 144 under the Securities
Act of 1933, as amended (the “Securities Act”). 
  
 3.
While this Sales Plan is in effect, Seller agrees not to enter into or alter any corresponding or hedging transaction or position with respect to the securities covered by this Sales Plan (including, without limitation, with respect to any
securities convertible or exchangeable into the Stock) and agrees not to alter or deviate from the terms of this Sales Plan. 
  
 4. Seller agrees that Seller shall not, directly or indirectly, communicate any information relating to the Stock or the Issuer to any employee of Morgan
Stanley or its affiliates who is involved, directly or indirectly, in executing this Sales Plan at any time while this Sales Plan is in effect. Any notice given to Morgan Stanley pursuant to this Sales Plan shall be given in accordance with
paragraph G.5. 

 5. (a) Seller agrees to provide Morgan Stanley with a certificate dated as of the date hereof and signed
by the Issuer substantially in the form of Exhibit A hereto prior to commencement of the Plan Sales Period (as defined below). 
  
 (b) Seller agrees to notify Morgan Stanley by telephone at the number set forth in paragraph G.5 below as soon as practicable if Seller becomes aware of
the occurrence of any event contemplated by paragraph 3 of the certificate set forth as Exhibit A hereto. Such notice shall indicate the anticipated duration of the restriction, but shall not include any other information about the nature of the
restriction or its applicability to Seller and shall not in any way communicate any material nonpublic information about the Issuer or its securities to Morgan Stanley. Such notice shall be in addition to the notice required to be given to Morgan
Stanley by the Issuer pursuant to the certificate set forth as Exhibit A hereto. 
  
 6. Seller agrees to complete, execute and deliver to Morgan Stanley a seller representation letter dated as of the date hereof substantially in the form of Exhibit B hereto prior to the commencement of the Plan Sales
Period. 
  
 7. The execution and delivery of this Sales Plan by
Seller and the transactions contemplated by this Sales Plan will not contravene any provision of applicable law or any agreement or other instrument binding on Seller or any of Seller’s affiliates or any judgment, order or decree of any
governmental body, agency or court having jurisdiction over Seller or Seller’s affiliates. 

 8. Seller has consulted with Seller’s own advisors as to the legal, tax, business, financial and
related aspects of, and has not relied upon Morgan Stanley or any person affiliated with Morgan Stanley in connection with, Seller’s adoption and implementation of this Sales Plan. Seller acknowledges that Morgan Stanley is not acting as a
fiduciary or an advisor for Seller. 
  
 9. Seller agrees that
until this Sales Plan has been terminated Seller shall not (i) enter into a binding contract with respect to the purchase or sale of Stock with another broker, dealer or financial institution (each, a “Financial Institution”), (ii)
instruct another Financial Institution to purchase or sell Stock or (iii) adopt a plan for trading with respect to Stock other than this Sales Plan. 
  
 10. (a) Seller agrees to make all filings, if any, required under Sections 13(d), 13(g) and 16 of the Exchange Act in a timely manner, to the extent any
such filings are applicable to Seller. 
  
 (b) Seller agrees that
Seller shall at all times during the Plan Sales Period (as defined below), in connection with the performance of this Sales Plan, comply with all applicable laws, including, without limitation, Section 16 of the Exchange Act and the rules and
regulations promulgated thereunder. 

 11. (a) Seller represents and warrants that the Stock to be sold pursuant to this Sales Plan is currently
eligible for sale under Rule 144. 
  
 (b) Seller agrees not to
take, and agrees to cause any person or entity with which Seller would be required to aggregate sales of Stock pursuant to paragraph (a)(2) or (e) of Rule 144 not to take, any action that would cause the sales hereunder not to meet all applicable
requirements of Rule 144. 
  
 (c) Seller agrees to complete,
execute and deliver to Morgan Stanley Forms 144 for the sales to be effected under this Sales Plan at such times and in such numbers as Morgan Stanley shall request, and Morgan Stanley agrees to file such Forms 144 on behalf of Seller as required by
applicable law. Seller understands and agrees that Morgan Stanley shall make one Form 144 filing at the beginning of each three-month period commencing upon the first Sale Day under this Sales Plan. 
  
 (d) Seller hereby grants Morgan Stanley a power of attorney to complete
and/or file on behalf of Seller any required Forms 144. Notwithstanding such power of attorney, Seller acknowledges that Morgan Stanley shall have no obligation to complete or file Forms 144 on behalf of Seller except as set forth in subparagraph
(c). 
  
 (e) Morgan Stanley agrees to conduct all sales pursuant
to this Sales Plan in accordance with the manner of sale requirement of Rule 144 of the Securities Act and in no event shall Morgan Stanley effect any sale if such sale 

 would exceed the then-applicable amount limitation under Rule 144, assuming Morgan Stanley’s sales pursuant to this
Sales Plan are the only sales subject to that limitation. 
  
 12.
Seller acknowledges and agrees that Seller does not have, and shall not attempt to exercise, any influence over how, when or whether to effect sales of Stock pursuant to this Sales Plan. 
  
 C. Implementation of the Plan 
  
 1. Seller hereby appoints Morgan Stanley to sell shares of Stock pursuant to the terms and conditions set forth below. Subject to such terms and
conditions, Morgan Stanley hereby accepts such appointment. 
  
 2.
Morgan Stanley is authorized to begin selling Stock pursuant to this Sales Plan on September 7, 2005 and shall cease selling Stock on the earliest to occur of (i) the date on which Morgan Stanley is required to suspend or terminate sales under the
Sales Plan pursuant to paragraph D.1 below, (ii) the date on which Morgan Stanley receives notice of the death of Seller, (iii) the date on which the Issuer or any other person publicly announces a tender or exchange offer with respect to the Stock
or a merger, acquisition, reorganization, recapitalization or comparable transaction affecting the securities of the Issuer as a result of which the Stock is to be exchanged or converted into shares of another company, (iv) the date on which Morgan
Stanley receives notice of the commencement or impending commencement of any proceedings in respect of or triggered by Seller’s bankruptcy or insolvency and (v): 
  
 X September 7, 2006 or 

 X the date that the aggregate number of shares of Stock sold pursuant to this Sales Plan reaches
360,000 shares (the “Total Sales Amount”) and 
  
 (the “Plan Sales
Period”). 
  
 3. (a) During the Plan Sales Period, Morgan
Stanley shall sell the Daily Sale Amount (as defined below) for the account of Seller on each Sale Day (as defined below), subject to the following restrictions, if desired: 
  
 X Refer to Exhibit C for the selling price parameters. 
  
 (b) A “Sale Day” is each Trading Day during a calendar week during the Plan Sales Period, provided that if any
Sale Day is not a Trading Day, such Sale Day shall be deemed to fall on the next succeeding Trading Day. A “Trading Day” is any day during the Plan Sales Period that the New York Stock Exchange (the “Principal Market”) is open
for business and the Stock is trading regular way on the Principal Market. 
  
 (c) The “Daily Sale Amount” for any Sale Day shall be as shown in Exhibit C: 
  
 (d) Subject to the restrictions set forth in paragraph C.3 (a) above, Morgan Stanley shall sell the Daily Sale Amount on each Sale Day under ordinary
principles of best execution at the then-prevailing market price. 

 (e) If, consistent with ordinary principles of best execution or for any other reason, Morgan Stanley
cannot sell the Daily Sale Amount on any Sale Day, then: 
  
 X Morgan Stanley’s obligation to sell Stock on such Sale Day pursuant to this Sales Plan shall be deemed to have been satisfied. 
  
 (f) The Daily Sale Amount, the Total Sale Amount, if applicable, and the Minimum Sale Price, if applicable, shall be adjusted automatically on a
proportionate basis to take into account any stock split, reverse stock split or stock dividend with respect to the Stock or any change in capitalization with respect to the Issuer that occurs during the Plan Sales Period. 
  
 4. Morgan Stanley shall not sell Stock hereunder at any time when:

  
 (i) Morgan Stanley, in its sole discretion,
has determined that a market disruption, banking moratorium, outbreak or escalation of hostilities or other crisis or calamity that could, in Morgan Stanley’s judgment, impact sales of the Stock has occurred; or 
  
 (ii) Morgan Stanley, in its sole discretion, has determined
that it is prohibited from doing so by a legal, contractual or regulatory restriction applicable 

 to it or its affiliates or to Seller or Seller’s affiliates (other than any such restriction
relating to Seller’s possession or alleged possession of material nonpublic information about the Issuer or the Stock); or 
  
 (iii) Morgan Stanley has received notice from the Issuer or Seller of the occurrence of any event contemplated by paragraph 3 of the
certificate set forth as Exhibit A hereto; or 
  
 (iv) Morgan Stanley has received notice from Seller to terminate the Sales Plan in accordance with paragraph D.1 below. 
  
 5. (a) Seller agrees to make appropriate arrangements with the Issuer and its transfer agent and stock plan administrator to permit Morgan Stanley to
furnish notice to the Issuer of the exercise of the Options and to have underlying shares delivered to Morgan Stanley as necessary to effect sales under this Sales Plan. Seller hereby authorizes Morgan Stanley to serve as Seller’s agent and
attorney-in-fact and, in accordance with the terms of this Sales Plan, to exercise the Options. Seller agrees to complete, execute and deliver to Morgan Stanley Stock Option Cashless Exercise Forms, for the exercise of Options pursuant to this Sales
Plan at such times and in such numbers as Morgan Stanley shall request. Stock received upon exercise of Options shall be delivered to an account at Morgan Stanley in the name of and for the benefit of Seller (the “Plan Account”).

 (b) On each day that sales are to be made under this Sales Plan, Morgan Stanley shall exercise a
sufficient number of Options to effect such sales in the manner specified below: 
  
 X options that have already vested. 
  
 Morgan Stanley shall in no event exercise any Option if at the time of exercise the exercise price of the Option is equal to or higher than the market price of the Stock. 
  
 (c) Morgan Stanley shall, in connection with the exercise of Options, remit to the Issuer the exercise price thereof along
with such amounts as may be necessary to satisfy withholding obligations. These amounts shall be deducted from the proceeds of sale of the Stock, together with interest thereon computed in accordance with Morgan Stanley’s customary practices.

  
 (d) To the extent that any Stock remains in the Plan Account
after the end of the Plan Sales Period or upon termination of this Sales Plan, Morgan Stanley agrees to return such Stock promptly to the Issuer’s transfer agent for relegending to the extent that such Stock would then be subject to transfer
restrictions in the hands of the Seller. 
  
 6. Morgan Stanley
shall in no event effect any sale under this Sales Plan if the Stock to be sold is not in the Plan Account or underlying an Option that is exercised in accordance with the terms of this Sales Plan on the day of such sale. 

 7. Morgan Stanley may sell Stock on any national securities exchange, in the over-the-counter market, on
an automated trading system or otherwise. Seller agrees that if Morgan Stanley is a market maker in the Stock at the time that any sale is to be made under this Sales Plan, Morgan Stanley may, at its sole discretion, purchase the Stock from Seller
in its capacity as market maker. 
  
 D. Termination 
  
 1. (a) This Sales Plan may be suspended or terminated by Seller at any time
upon three days prior written notice sent to Morgan Stanley by overnight mail and by facsimile at the address and fax number set forth in paragraph G.5 below. Seller agrees that Seller shall not suspend or terminate this Sales Plan except upon
consultation with Seller’s own legal advisors. 
  
 (b) This
Sales Plan shall be suspended or, at Morgan Stanley’s option, terminated, if Morgan Stanley receives notice from the Issuer of the occurrence of any event contemplated by paragraph 3 of the certificate set forth as Exhibit A hereto. 

 
 2. Seller agrees that Morgan Stanley will execute this Sales Plan in
accordance with its terms and will not be required to suspend or terminate any sales of the Stock unless Morgan Stanley has received notice from Seller or the Issuer in accordance with paragraph D.1 above at least three days prior to the date on
which this Sales Plan is to be suspended or terminated. 

 3. This Sales Plan may be amended by Seller only upon the written consent of Morgan Stanley and receipt
by Morgan Stanley of the following documents, each dated as of the date of such amendment: 
  
 (i) a representation signed by the Issuer substantially in the form of Exhibit A hereto, 
  
 (ii) a certificate signed by Seller certifying that the
representations and warranties of Seller contained in this Sales Plan are true at and as of the date of such certificate as if made at and as of such date and 
  

(iii) a seller representation letter completed and executed by Seller substantially in the form of Exhibit B hereto. 
  
 E. Indemnification; Limitation of Liability 
  
 1. (a) Each party agrees to indemnify and hold harmless the other and its
directors, officers, employees and affiliates from and against all claims, losses, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action
or claim) arising out of or attributable to Morgan Stanley’s actions taken or not taken in compliance with this Sales Plan or arising out of or attributable to any breach by Seller of this Sales Plan (including Seller’s representations and
warranties hereunder) or any violation by Seller of applicable laws or regulations. This indemnification shall survive termination of this Sales Plan. 

 (b) Notwithstanding any other provision hereof, Morgan Stanley shall not be liable to Seller for:

  
 (i) special, indirect, punitive, exemplary or
consequential damages, or incidental losses or damages of any kind, even if advised of the possibility of such losses or damages or if such losses or damages could have been reasonably foreseen, or 
  
 (ii) any failure to perform or to cease performance or any
delay in performance that results from a cause or circumstance that is beyond its reasonable control, including but not limited to failure of electronic or mechanical equipment, strikes, failure of common carrier or utility systems, severe weather,
market disruptions or other causes commonly known as “acts of God”. 
  
 2. Seller acknowledges and agrees that in performing Seller’s obligations hereunder neither Morgan Stanley nor any of its affiliates nor any of their respective officers, employees or other representatives is
exercising any discretionary authority or discretionary control respecting management of Seller’s assets, or exercising any authority or control respecting management or disposition of Seller’s assets, or otherwise acting as a fiduciary
(within the meaning of Section 3(21) of the Employee Retirement Income Security Act of 1974, as amended, or Section 

 2510.3-21 of the Regulations promulgated by the United States Department of Labor) with respect to Seller or
Seller’s assets. 
  
 Without limiting the foregoing, Seller
further acknowledges and agrees that neither Morgan Stanley nor any of its affiliates nor any of their respective officers, employees or other representatives has provided any “investment advice” within the meaning of such provisions, and
that no views expressed by any such person will serve as a primary basis for investment decisions with respect to Seller’s assets. 
  
 F. Agreement to Arbitrate 
  
 1. (a) Any dispute between Seller and Morgan Stanley arising out of, relating to or in connection with this Sales Plan or any transaction relating to
this Sales Plan shall be determined by arbitration only before the New York Stock Exchange, Inc.; the National Association of Securities Dealers, Inc.; or the Municipal Securities Rulemaking Board, as Seller may elect. If Seller makes no written
election addressed to Morgan Stanley by registered mail within five days after receiving a written demand for arbitration from Morgan Stanley, Seller authorizes Morgan Stanley to elect one of the above listed forums for Seller. 
  
 (b) Unless rules of the arbitral forum dictate otherwise, any arbitration
proceeding between Seller and Morgan Stanley shall be held at a location at which 

 the selected forum regularly conducts such proceedings nearest to the Morgan Stanley office carrying Seller’s
accounts at the time the claim arose; this venue shall apply even if Seller has related disputes with other parties which cannot be resolved in the same locale. Except for simplified proceedings (small claims), any arbitration proceeding between
Seller and Morgan Stanley shall be heard and decided by a panel of not fewer than three arbitrators. 
  
 (c) The law of the State of New York shall apply in all respects, including but not limited to determination of applicable statutes of limitation and
available remedies. The award of the arbitrator or a majority of arbitrators shall be final, and judgment on the award may be entered in any state or federal court having jurisdiction. 
  
 2. Seller represents that Seller understands the terms of the above
arbitration clause as follows: 
  
 (i)
Arbitration is final and binding on the parties. 
  
 (ii) The parties are waiving their right to seek remedies in court, including the right to jury trial. 
  
 (iii) Pre-arbitration discovery is generally more limited than and different from court proceedings. 

 (iv) The arbitrators’ award is not required to include factual findings or legal
reasoning, and any party’s right to appeal or seek modification of rulings by the arbitrators is strictly limited. 
  
 (v) The panel of arbitrators will typically include a minority of arbitrators who were or are affiliated with the securities industry.

  
 (vi) No person shall bring a putative
or certified class action to arbitration, nor seek to enforce any pre-dispute arbitration agreement against any person who has initiated in court a putative class action or who is a member of a putative class who has not opted out of the class with
respect to any claims encompassed by the putative class action until: 
  
 (A) the class certification is denied; 
  
 (B) the class is decertified; or 
  
 (C) the customer is excluded from the class by the court. 
  
 Such forbearance to enforce an agreement to arbitrate shall not constitute a waiver of any rights under this Sales Plan except to the
extent stated herein. 
  
 G. General 
  
 1. Proceeds from each sale of Stock effected under the Sales Plan will be
delivered to Seller’s account 

 322-110617-145 on a normal three-day settlement basis less any commission, commission equivalent, mark-up or differential
and other expenses of sale to be paid to Morgan Stanley. 
  
 2. In
the event that it is necessary for Morgan Stanley to borrow or purchase shares of Stock in order to complete any sale on behalf of Seller pursuant to this Sales Plan, Seller authorizes Morgan Stanley to borrow or purchase such shares and agrees to
be responsible for any expense or loss which Morgan Stanley may sustain relating to such borrowing or purchase, including any expense or loss Morgan Stanley may sustain as a result of its inability to borrow or purchase shares of the Stock to
complete its delivery obligation. 
  
 3. Seller and Morgan Stanley
acknowledge and agree that this Sales Plan is a “securities contract,” as such term is defined in Section 741(7) of Title 11 of the United States Code (the “Bankruptcy Code”), entitled to all of the protections given such
contracts under the Bankruptcy Code. 
  
 4. This Sales Plan
constitutes the entire agreement between the parties with respect to this Sales Plan and supercedes any prior agreements or understandings with regard to the Sales Plan. 

 5. All notices to Morgan Stanley under this Sales Plan shall be given to Morgan Stanley in the manner
specified by this Sales Plan by telephone at 201-395-6821, by facsimile at 201-200-2978 or 201-200-2979 or by certified mail to the address below: 
  
 Morgan Stanley DW Inc. 
 Harborside Financial
Center 
 Plaza III, 1st Floor 
 Jersey City, N.J. 07311 
 Attn: Wayne Rothstein 
 10b5-1 Administration Unit 
  
 6. Seller’s rights and obligations under this Sales Plan may not be
assigned or delegated without the written permission of Morgan Stanley. 
  
 7. This Sales Plan may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
  
 8. If any provision of this Sales Plan is or becomes inconsistent with any
applicable present or future law, rule or regulation, that provision will be deemed modified or, if necessary, rescinded in order to comply with the relevant law, rule or regulation. All other provisions of this Sales Plan will continue and remain
in full force and effect. 
  
 9. This Sales Plan shall be governed
by and construed in accordance with the internal laws of the State of New York and may be modified or amended only by a writing signed by the parties hereto. 
  
 NOTICE: THIS AGREEMENT CONTAINS A PRE-DISPUTE ARBITRATION CLAUSE IN PARAGRAPHS F.1 AND F.2. 

 IN WITNESS WHEREOF, the undersigned have signed this Sales Plan as of the date first written above.

  

			
	Joseph L. von Rosenberg III
	
	 /s/ Joseph L. von Rosenberg III

	
	Morgan Stanley DW Inc.
	
	 /s/ Richard J. Fischer

	Name:	 	Richard J. Fischer
	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]